Microbot Medical launches full market release of LIBERTY robotic system after successful limited release

Microbot Medical Inc.

LIBERTY adopted by multiple healthcare systems including Emory Healthcare and Tampa General Hospital during limited market release.
Used commercially across procedures: PAE, UFE, GAE, Y90 mapping/deliveries, peripheral interventions.
Full market release commenced at SIR Annual Scientific Meeting in Toronto (April 11-15, 2026).
Sales footprint expanded from 4 to 8 territories; target of 12 U.S. territories by end of 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.